Khan et al. genotyped 140 thyroid cancer patients and 200 cancer-free controls from Kashmir Valley to evaluate the association between the TP53 gene rs1042522 C>G polymorphism and the risk of differentiated thyroid cancer [38]. This evidence concerns the gene TP53 and thyroid gland carcinoma.